WCG Clinical, Inc. – NASDAQ:WCGC

WCG Clinical, Inc., through its subsidiaries, provides solutions to enhance the quality and efficiency of clinical research in the United States. The company operates in two segments: Ethical Review and Clinical Trial Solutions. The Ethical Review segment provides technology-enabled services that ensure clinical trials respect the rights and protect the welfare of patient participants. This segment also offers a hosted software application to its clients on a subscription basis for research management and trial submissions. The Clinical Trial Solutions segment offers an integrated suite of approximately 40 technology-enabled solutions that support the conduct of effective clinical trials. This segment provides proprietary software and specialty clinical consulting services, which provide integrated, end-to-end support of workflows along the clinical trial process. The company serves biopharmaceutical companies and contract research organizations, trial sites, institutions, and investigators, as well as patients and advocacy groups. WCG Clinical, Inc. was founded in 1968 and is headquartered in Princeton, New Jersey.